Osteoarthritis of Knee: Clinical Trials

8 trials for Osteoarthritis of Knee, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 unknown. 8 Phase 2, 5 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Completed 6, Unknown 2
Phase 15Completed 4, Unknown 1
Phase 31Unknown 1

Follow Osteoarthritis of Knee: new trials by email Literature Review of Osteoarthritis of Knee trials Research Report on Osteoarthritis of Knee

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1/2a Study to Evaluate Single Intraarticular Injections of 3 Dose Levels of SYN321 and Placebo in Patients With Symptomatic Knee Osteoarthritis
SYN321, Placebo - Osteoarthritis of Knee
Phase 1 / Phase 2CompletedSynartro AB352025-08-192026-03-06
A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee
Cryopreserved Devitalized Adipose Tissue Allograft, Normal Saline (Placebo) - Osteoarthritis of Knee
Phase 1 / Phase 2CompletedBritecyte462025-05-052026-09-08
Clinical Trial to Assess Efficacy, Tolerability of Rising Doses of Clodronate in Painful Knee Osteoarthritis Patients
Clodronate, Placebo - Osteoarthritis of Knee
Phase 2 / Phase 3UnknownSPA Società Prodotti Antibiotici S.p.A.2962023-10-122024-02-16
Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases
MesoCellA-Ortho administration, HA administration - Osteoarthritis of Knee
Phase 1 / Phase 2CompletedJagiellonian University1922022-01-052024-03-21
Efficacy and Safety of MM-II for Treatment of Knee Pain in Subjects With Symptomatic Knee Osteoarthritis
MM-II dose I, MM-II dose II, MM-II dose III - Osteoarthritis of Knee
Phase 2CompletedSun Pharmaceutical Industries Limited3972020-12-222024-08-29
Short-term Efficacy of Antidepressant in Patients Underwent TKA
Duloxetine Hydrochloride - Osteoarthritis Of Knee
Phase 1 / Phase 2UnknownDalian Municipal Central Hospital322017-01-012017-04-14
Human Autologous MSCs for the Treatment of Mid to Late Stage Knee OA
1 x 10^6 MSCs, 10 x 10^6 MSCs, 50 x 10^6 MSCs - Osteoarthritis of Knee
Phase 1 / Phase 2CompletedJas Chahal122015-02-012019-09-27
Allogeneic Mesenchymal Stem Cells in Osteoarthritis
Ex- vivo cultured adult allogeneic MSCs, Plasmalyte-A - Osteoarthritis of Knee
Phase 2CompletedStempeutics Research Pvt Ltd602011-11-012016-05-12

Narrower conditions

Osteoarthritis, Knee (8)  ·  Osteoarthritis (4)  ·  Depression (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Obesity (1)  ·  Pain (1)

Broader conditions

Arthritis (8)  ·  Joint Diseases (8)  ·  Musculoskeletal Diseases (8)  ·  Rheumatic Diseases (8)  ·  Osteoarthritis (4)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Body Weight (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Neurologic Manifestations (1)

Interventions

Clodronic Acid (1)  ·  Duloxetine Hydrochloride (1)  ·  Plasmalyte A (1)  ·  Saline Solution (1)

Sponsors

Britecyte (1)  ·  Dalian Municipal Central Hospital (1)  ·  Jagiellonian University (1)  ·  Jas Chahal (1)  ·  SPA Società Prodotti Antibiotici S.p.A. (1)  ·  Stempeutics Research Pvt Ltd (1)  ·  Sun Pharmaceutical Industries Limited (1)  ·  Synartro AB (1)

Countries

United States (2)  ·  Canada (1)  ·  China (1)  ·  Denmark (1)  ·  Hong Kong (1)  ·  India (1)  ·  Italy (1)  ·  Poland (1)  ·  Sweden (1)

Top investigators

Alla Danilkovitch (1)  ·  Bhibas Dasgupta, MS (1)  ·  Jas Chahal, MD, MSc (1)  ·  Krzysztof Ficek, Prof., MD, PhD, DSc (1)  ·  Naresh Shetty, MS (1)  ·  QI Zhiming, MD (1)  ·  Shrikant Wagh, MD (1)  ·  Sowmya Viswanathan, PhD (1)  ·  Vikas Agarwal, MD., DM (1)  ·  Vivek Pandey, MS (1)

Results publications

PMID 27993154

NIH funding

2019 (1)